Cargando…
Differences in the Composition of Gut Microbiota between Patients with Parkinson’s Disease and Healthy Controls: A Cohort Study
Gut microbiome and colonic inflammation can be associated with the predisposition and progression of Parkinson’s disease (PD). The presented study aimed to compare gastrointestinal microbiota composition between patients diagnosed with PD and treated only with Levodopa to healthy controls. In this p...
Autores principales: | Zapała, Barbara, Stefura, Tomasz, Wójcik-Pędziwiatr, Magdalena, Kabut, Radosław, Bałajewicz-Nowak, Marta, Milewicz, Tomasz, Dudek, Alicja, Stój, Anastazja, Rudzińska-Bar, Monika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658639/ https://www.ncbi.nlm.nih.gov/pubmed/34884399 http://dx.doi.org/10.3390/jcm10235698 |
Ejemplares similares
-
The Role of the Western Diet and Oral Microbiota in Parkinson’s Disease
por: Zapała, Barbara, et al.
Publicado: (2022) -
Does Postoperative Oral and Intestinal Microbiota Correlate with the Weight-Loss Following Bariatric Surgery?—A Cohort Study
por: Stefura, Tomasz, et al.
Publicado: (2020) -
Differences in Compositions of Oral and Fecal Microbiota between Patients with Obesity and Controls
por: Stefura, Tomasz, et al.
Publicado: (2021) -
The Role of Single Nucleotide Polymorphisms of Monoamine Oxidase B, Dopamine D2 Receptor, and DOPA Decarboxylase Receptors Among Patients Treated for Parkinson’s Disease
por: Zapała, Barbara, et al.
Publicado: (2022) -
Comparison of iSeq and MiSeq as the two platforms for 16S rRNA sequencing in the study of the gut of rat microbiome
por: Salamon, Dominika, et al.
Publicado: (2022)